TY - JOUR
T1 - Covid-19 associated rhino-orbital mucormycosis complicated by gangrenous and bone necrosis—a case report from honduras
AU - Palou, Elsa Yolanda
AU - Ramos, María Auxiliadora
AU - Cherenfant, Emec
AU - Duarte, Adoni
AU - Fuentes-Barahona, Itzel Carolina
AU - Zambrano, Lysien I.
AU - Muñoz-Lara, Fausto
AU - Montoya-Ramirez, Sandra Aracely
AU - Cardona-Ortiz, Alex Francisco
AU - Valle-Reconco, Jorge Alberto
AU - Montenegro-Idrogo, Juan J.
AU - Bonilla-Aldana, D. Katterine
AU - Paniz-Mondolfi, Alberto E.
AU - Rodriguez-Morales, Alfonso J.
N1 - Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/8
Y1 - 2021/8
N2 - Background: Mucormycosis is a life-threatening invasive fungal infection most commonly observed in immunocompromised patients. Throughout the COVID-19 pandemic, a growing number of Mucorales associated infections, now termed COVID-19 associated mucormycosis (CAM), have been reported. Despite an increase in fatality reports, no cases of rhino-orbital CAM complicated with gangrenous bone necrosis have been described in the literature to date. Case: A 56-year-old male with a recent COVID-19 diagnosis developed rhino-orbital mucormycosis after 22 days of treatment with dexamethasone. Cultures and histopathological assessment of tissue biopsy confirmed the diagnosis. The patient survived after treatment with amphotericin B. Conclusions: Mucormycosis is an invasive fungal infection affecting mostly immunocompromised patients. Along with the COVID-19 pandemic, the inappropriate use of steroids, in addition to concurrent risk factors, such as diabetes, has led to an increase in the occurrence of these devastating mycoses, leading to the development of severe presentations and complications, as observed in many cases. Early diagnosis and prompt treatment are crucial in order to avoid dissemination and fatal outcomes.
AB - Background: Mucormycosis is a life-threatening invasive fungal infection most commonly observed in immunocompromised patients. Throughout the COVID-19 pandemic, a growing number of Mucorales associated infections, now termed COVID-19 associated mucormycosis (CAM), have been reported. Despite an increase in fatality reports, no cases of rhino-orbital CAM complicated with gangrenous bone necrosis have been described in the literature to date. Case: A 56-year-old male with a recent COVID-19 diagnosis developed rhino-orbital mucormycosis after 22 days of treatment with dexamethasone. Cultures and histopathological assessment of tissue biopsy confirmed the diagnosis. The patient survived after treatment with amphotericin B. Conclusions: Mucormycosis is an invasive fungal infection affecting mostly immunocompromised patients. Along with the COVID-19 pandemic, the inappropriate use of steroids, in addition to concurrent risk factors, such as diabetes, has led to an increase in the occurrence of these devastating mycoses, leading to the development of severe presentations and complications, as observed in many cases. Early diagnosis and prompt treatment are crucial in order to avoid dissemination and fatal outcomes.
KW - COVID-19
KW - Coinfection
KW - Honduras
KW - Mucorales
KW - Mucormycosis
KW - Opportunistic
KW - SARS-CoV-2
UR - http://www.scopus.com/inward/record.url?scp=85111713144&partnerID=8YFLogxK
U2 - 10.3390/vaccines9080826
DO - 10.3390/vaccines9080826
M3 - Original Article
AN - SCOPUS:85111713144
SN - 2076-393X
VL - 9
JO - Vaccines
JF - Vaccines
IS - 8
M1 - 826
ER -